Tuesday, May 24, 2016

AbbVie, Amgen and Roche's Place in the Biosimilar Industry

Bidness ETC-3 hours ago
Amgen is the first victim of biosimilars; its cancer drug Neupogen's biosimilar has ... biosimilar market will grow at a compounded annual growth rate of 22.1%

No comments: